Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Promino Nutritional Sciences Inc. C.MUSL

Alternate Symbol(s):  MUSLF

Promino Nutritional Sciences Inc., formerly Element Nutritional Sciences Inc., is a research-driven Canadian nutraceutical company. The Company is specializing in the development of science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. The Company's lead product, Rejuvenate, is a formulation that is clinically proven to... see more

CSE:MUSL - Post Discussion

Promino Nutritional Sciences Inc. > $ELMT.c recently completed production trials for their Rejuv
View:
Post by stockpatrol on Jun 24, 2022 6:41pm

$ELMT.c recently completed production trials for their Rejuv

$ELMT.c recently completed production trials for their Rejuvenate Muscle Activator 
 
https://twitter.com/TheTSXDude/status/1540091344579792896
 
This product is a ready to drink muscle activator that is proven to result in protein synthesis. 
 
I think this is a good direction for $ELMT.c to take their products considering how big the supplement market is, currently worth $12.58B USD.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities